Specific Gene Mutations May Affect Response to Tamoxifen in Breast Cancer

Mutations within the CYP2D6 gene may affect the way in which a patient with hormone-positive breast cancer responds to tamoxifen (Nolvadex®). These results were recently published in the Journal of the National Cancer Institute....
Read More...
[Source: Breast Cancer News]

Young Age Linked with Worse Breast Cancer Prognosis

According to the results of a study conducted in Korea, breast cancer patients under the age of 35 have a worse prognosis than patients between the ages of 35 and 50, and may also be less responsive to tamoxifen (Nolvadex®). These results were published in the Journal of Clinical Oncology....
Read More...
[Source: Breast Cancer News]

OncoVue� Offers Improved Estimation of Risk for Breast Cancer

OncoVue® offers a significantly more accurate estimation of the risk of breast cancer than the Gail Model, according to the results of a study presented at the San Antonio Breast Cancer Symposium on December 12, 2008....
Read More...
[Source: Breast Cancer News]

Adjuvant Taxotere� Improves Breast Cancer Survival

According to the results of a study presented at the 2007 San Antonio Breast Cancer Symposium, adjuvant chemotherapy with Taxotere® (docetaxel) and cylophosphamide results in better survival than adjuvant chemotherapy with doxorubicin and cyclophosphamide....
Read More...
[Source: Breast Cancer News]

Research Continues on Dietary Fat and Breast Cancer

A large study conducted in Sweden and published in the British Journal of Cancer found no overall association between total dietary fat or specific types of dietary fat and risk of breast cancer....
Read More...
[Source: Breast Cancer News]

Reduced Breast Density May Indicate a Response to Tamoxifen

New research indicates that when the use of tamoxifen (Nolvadex®) results in a reduction of breast density, this change in breast density serves as an indicator that the drug is effectively working to reduce the risk of breast cancer. In other words, changes in breast density may indicate whether a woman is actually benefiting from the use of tamoxifen. The results of this study were presented at the San Antonio Breast Cancer Symposium on Saturday December 13, 2008....
Read More...
[Source: Breast Cancer News]

Doug Reinhardt spent $2 mil to make his penis itch

Doug Reinhardt reportedly dropped over $2 million on Paris Hilton during their relationship, according to RadarOnline: "Doug never used Paris. He spent 2 million dollars on her over the course of a year and a half," a source revealed... ...read full story
Read More...
[Source: The Superficial - Because You're Ugly]